Pathologic Response, When Increased by Longer Interval, Is a Marker but Not the Cause of Good Prognosis in Rectal Cancer: 17-year Follow-up of the Lyon R90-01 Randomized Trial-Reference-Cited by-同舟云学术

Pathologic Response, When Increased by Longer Interval, Is a Marker but Not the Cause of Good Prognosis in Rectal Cancer: 17-year Follow-up of the Lyon R90-01 Randomized Trial

Published:2016-03 Issue:3 Volume:94 Page:544-553
ISSN:0360-3016
Container-title:International Journal of Radiation Oncology*Biology*Physics
language:en
Short-container-title:International Journal of Radiation Oncology*Biology*Physics

Author:

Cotte Eddy,Passot Guillaume,Decullier Evelyne^ORCID,Maurice Christelle,Glehen Olivier,François Yves,Lorchel Fabrice,Chapet Olivier,Gerard Jean-Pierre^ORCID

Publisher

Elsevier BV

Subject

Cancer Research,Radiology Nuclear Medicine and imaging,Oncology,Radiation

Reference30 articles.

1. Radiation dose-response model for locally advanced rectal cancer after preoperative chemoradiation therapy;Appelt;Int J Radiat Oncol Biol Phys,2013

2. Proportion of second cancers attributable to radiotherapy treatment in adults: A cohort study in the US SEER cancer registries;Berrington de Gonzalez;Lancet Oncol,2011

3. Fluorouracil-based adjuvant chemotherapy after preoperative chemoradiotherapy in rectal cancer: Long-term results of the EORTC 22921 randomised study;Bosset;Lancet Oncol,2014

4. Chemotherapy with preoperative radiotherapy in rectal cancer;Bosset;N Engl J Med,2006

5. Randomized phase III study comparing preoperative radiotherapy with chemoradiotherapy in nonresectable rectal cancer;Braendengen;J Clin Oncol,2008

Cited by 51 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Oncological risks associated with the planned watch-and-wait strategy using total neoadjuvant treatment for rectal cancer: A narrative review;Cancer Treatment Reviews;2024-09

2. Predictive and Prognostic Factors Related to Chemoradioresistance in Neoadjuvant Treatment of Locally Advanced Rectal Cancer at Panama;Cancer Research Journal;2024-04-12

3. Does the Addition of Radiation to Neoadjuvant Systemic Therapy Improve Outcomes for Patients with Resected Pancreatic Adenocarcinoma? Analysis of the National Cancer Database;2024-03-04

4. Oncologic outcomes of watch-and-wait strategy or surgery for low to intermediate rectal cancer in clinical complete remission after adjuvant chemotherapy: a systematic review and meta-analysis;International Journal of Colorectal Disease;2023-10-03

5. Time Interval Between the End of Neoadjuvant Therapy and Elective Resection of Locally Advanced Rectal Cancer in the CRONOS Study;JAMA Surgery;2023-09-01